TotalMarketCap

Clene

CLNNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$56.161 M

$3.90 -4.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Clene (CLNN) has a market capitalization of $56.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$200.0K

#3549 by revenue

Earnings

-$26.2M

Loss-making

Shares outstanding

14,400,175

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #323XBiotechXBIT$57.0M
  2. #324Nomad Power SolutionsNMAD$56.4M
  3. #325CleneCLNN$56.2M
  4. #326Xilio TherapeuticsXLO$55.9M
  5. #327Boundless BioBOLD$55.8M

What if Clene were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,960,870

Per share 502,787× higher

Bitcoin $1.53T

$106,099.27

Per share 27,205× higher

Apple $5.02T

$348,314.00

Per share 89,311× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Clene are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.